Effect of giving Gabapentin and trihexphenidyl when compared to Trihexphenidyl alone for reducing dystonia in children with cerebral palsy
Not Applicable
- Conditions
- Health Condition 1: G808- Other cerebral palsy
- Registration Number
- CTRI/2019/04/018603
- Lead Sponsor
- JAYA SHANKAR KAUSHIK
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children aged between 3-9 years with dyskinetic cerebral palsy (Gross Motor Functional
Classification System 4-5).
Exclusion Criteria
I.Children who have undergone any surgical such as orthopedic surgery or botulinum toxin injection in the preceding six months.
II.A neurological or neurodegenerative condition known to mimic cerebral palsy including those with diurnal variations, parkinsonian features, suspected inborn errors of
metabolism, or those with presumed genetic causes.
III.Children with known renal, pulmonary, cardiac or hepatic dysfunction.
IV. Children with associated drug-resistant epilepsy.
V.Children with known hypersensitivity to the study drugs.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method